The systemic immune-inflammation index (SIII) is a marker studied in multiple types of
urologic cancer. This systematic review evaluates the association between SIII values with …

Skin cancer is a widespread worldwide health concern, manifesting in many subtypes such
as squamous cell carcinoma, basal cell carcinoma, and melanoma. Although all these types …

Bibliometric methods were used to analyze publications on artificial intelligence in skin
cancer from 2010 to 2022, aiming to explore current publication trends and future directions …

Simple Summary Unlike the neutrophil/lymphocyte ratio (NLR), more complex complete
blood count (CBC)-based systemic immune-inflammation cancer biomarkers have recently …

As one of the deadliest forms of skin cancers, malignant melanoma is the most common
cause of death from this type of cancer. Malignant melanoma has a steadily increasing …

Introduction Advanced malignant melanoma is a very aggressive disease, historically with
poor prognosis before the new advances with immunotherapy and targeted therapies that …

The prognostic value of the neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and
monocyte-lymphocyte ratio in patients with melanoma has yielded controversial results in …

Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with diminished immunotherapy
response in metastatic melanoma. Although NLR assessment in peripheral blood is …

The prognosis of acromelanomas (AM) is worse. The objective of this study was to
investigate the clinical features of distant metastasis of AM and the factors affecting the …

Climate change represents a major existential threat facing the global community, and it has
already begun to affect human health in a multitude of ways. This article highlights and …